Figures & data
Figure 1. Physician estimate of therapy phase when assessing MRD. % of patients; counts not mutually exclusive.
![Figure 1. Physician estimate of therapy phase when assessing MRD. % of patients; counts not mutually exclusive.](/cms/asset/7f4a4725-9d06-4070-ab6d-526ca6754633/yhem_a_1510068_f0001_c.jpg)
Figure 2. Physician-ranked reasons for assessing MRD in patients with B-cell ALL among adult and pediatric treaters. % of physicians ranking reason in top 3. Data labels less than 7% are not shown, except for Total Rank %.
![Figure 2. Physician-ranked reasons for assessing MRD in patients with B-cell ALL among adult and pediatric treaters. % of physicians ranking reason in top 3. Data labels less than 7% are not shown, except for Total Rank %.](/cms/asset/7b8d5434-66e8-4f27-9a1d-0e953a7675ee/yhem_a_1510068_f0002_c.jpg)
Figure 3. Physician agreement with MRD testing attitudes and beliefs among adult and pediatric treaters. % of physicians, 1–7 scale (1 ‘completely disagree’; 7 ‘completely agree’). Data labels less than 10% are not shown.
![Figure 3. Physician agreement with MRD testing attitudes and beliefs among adult and pediatric treaters. % of physicians, 1–7 scale (1 ‘completely disagree’; 7 ‘completely agree’). Data labels less than 10% are not shown.](/cms/asset/c92750a4-6811-4de3-a5c4-08a668b3c29c/yhem_a_1510068_f0003_c.jpg)
Figure 4. Physician agreement with MRD testing attitudes and beliefs among academic and community treaters. % of Physicians, 1–7 scale 1 ‘completely disagree’ 7 ‘completely agree’. Data labels less than 10% are not shown.
![Figure 4. Physician agreement with MRD testing attitudes and beliefs among academic and community treaters. % of Physicians, 1–7 scale 1 ‘completely disagree’ 7 ‘completely agree’. Data labels less than 10% are not shown.](/cms/asset/ed21233a-3cbf-4b96-9932-d06fd8c4eeb7/yhem_a_1510068_f0004_c.jpg)